|
1
|
Herszényi L and Tulassay Z: Epidemiology
of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci.
14:249–258. 2010.PubMed/NCBI
|
|
2
|
Compare D, Rocco A and Nardone G: Risk
factors in gastric cancer. Eur Rev Med Pharmacol Sci. 14:302–308.
2010.PubMed/NCBI
|
|
3
|
Wang J, Ni Z, Duan Z, Wang G and Li F:
Altered expression of hypoxia-inducible factor-1α (HIF-1α) and its
regulatory genes in gastric cancer tissues. PLoS One. 9:e998352014.
View Article : Google Scholar
|
|
4
|
Liu X, Liu Q, Fan Y, Wang S, Liu X, Zhu L,
Liu M and Tang H: Downregulation of PPP2R5E expression by miR-23a
suppresses apoptosis to facilitate the growth of gastric cancer
cells. FEBS Lett. 588:3160–3169. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
DeBerardinis RJ, Lum JJ, Hatzivassiliou G
and Thompson CB: The biology of cancer: Metabolic reprogramming
fuels cell growth and proliferation. Cell Metab. 7:11–20. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu D, Zhang L, Shen Z, Tan F, Hu Y, Yu J
and Li G: Clinicopathological Significance of NMIIA overexpression
in human gastric cancer. Int J Mol Sci. 13:15291–15304. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xia ZK, Yuan YC, Yin N, Yin BL, Tan ZP and
Hu YR: Nonmuscle myosin IIA is associated with poor prognosis of
esophageal squamous cancer. Dis Esophagus. 25:427–436. 2012.
View Article : Google Scholar
|
|
8
|
Derycke L, Stove C, Vercoutter-Edouart AS,
De Wever O, Dollé L, Colpaert N, Depypere H, Michalski JC and
Bracke M: The role of non-muscle myosin IIA in aggregation and
invasion of human MCF-7 breast cancer cells. Int J Dev Biol.
55:835–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Betapudi V, Licate LS and Egelhoff TT:
Distinct roles of nonmuscle myosin II isoforms in the regulation of
MDA-MB-231 breast cancer cell spreading and migration. Cancer Res.
66:4725–4733. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lamant L, Gascoyne RD, Duplantier MM,
Armstrong F, Raghab A, Chhanabhai M, Rajcan-Separovic E, Raghab J,
Delsol G and Espinos E: Non-muscle myosin heavy chain (MYH9): A new
partner fused to ALK in anaplastic large cell lymphoma. Gene
Chromosomes Cancer. 37:427–432. 2003. View Article : Google Scholar
|
|
11
|
Liang S, He L, Zhao X, Miao Y, Gu Y, Guo
C, Xue Z, Dou W, Hu F, Wu K, et al: MicroRNA let-7f inhibits tumor
invasion and metastasis by targeting MYH9 in human gastric cancer.
PLoS One. 6:e184092011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Z, Wang Y, Dong S, Ge C, Xiao Y, Li R,
Ma X, Xue Y, Zhang Q, Lv J, et al: Association of CXCR1 and 2
expressions with gastric cancer metastasis in ex vivo and tumor
cell invasion in vitro. Cytokine. 69:6–13. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Matsuoka J, Yashiro M, Sakurai K, Kubo N,
Tanaka H, Muguruma K, Sawada T, Ohira M and Hirakawa K: Role of the
stemness factors sox2, oct3/4 and nanog in gastric carcinoma. J
Surg Res. 174:130–135. 2012. View Article : Google Scholar
|
|
14
|
Davies C and Tournier C: Exploring the
function of the JNK (c-Jun N-terminal kinase) signalling pathway in
physiological and pathological processes to design novel
therapeutic strategies. Biochem Soc Trans. 40:85–89. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Johnson GL and Nakamura K: The c-jun
kinase/stress-activated pathway: Regulation, function and role in
human disease. Biochim Biophys Actas. 1773:1341–1348. 2007.
View Article : Google Scholar
|
|
16
|
Ma J, Zhang L, Han W, Shen T, Ma C, Liu Y,
Nie X, Liu M, Ran Y and Zhu D: Activation of JNK/c-Jun is required
for the proliferation, survival and angiogenesis induced by EET in
pulmonary artery endothelial cells. J Lipid Res. 53:1093–1105.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hui L, Zatloukal K, Scheuch H, Stepniak E
and Wagner EF: Proliferation of human HCC cells and chemically
induced mouse liver cancers requires JNK1-dependent p21
downregulation. J Clin Invest. 118:3943–3953. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen N, Nomura M, She QB, Ma WY, Bode AM,
Wang L, Flavell RA and Dong Z: Suppression of skin tumorigenesis in
c-Jun NH2-terminal kinase-2-deficient mice. Cancer Res.
61:3908–3912. 2001.PubMed/NCBI
|
|
19
|
Wu K, Liu BH, Zhao DY and Zhao Y: Effect
of vitamin E succinate on expression of TGF-beta1, c-Jun and JNK1
in human gastric cancer SGC-7901 cells. World J Gastroenterol.
7:83–87. 2001. View Article : Google Scholar
|
|
20
|
Zhao Y, Zhao X, Yang B, Neuzil J and Wu K:
α-Tocopheryl succinate-induced apoptosis in human gastric cancer
cells is modulated by ERK1/2 and c-Jun N-terminal kinase in a
biphasic manner. Cancer Lett. 247:345–352. 2007. View Article : Google Scholar
|
|
21
|
Xia HH, He H, De Wang J, Gu Q, Lin MC, Zou
B, Yu LF, Sun YW, Chan AO, Kung HF and Wong BC: Induction of
apoptosis and cell cycle arrest by a specific c-Jun NH2-terminal
kinase (JNK) inhibitor, SP-600125, in gastrointestinal cancers.
Cancer Lett. 241:268–274. 2006. View Article : Google Scholar
|
|
22
|
Qi X, Pramanik R, Wang J, Schultz RM,
Maitra RK, Han J, DeLuca HF and Chen G: The p38 and JNK pathways
cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and
sensitize human breast cancer cells to vitamin D(3)-induced growth
inhibition. J Biol Chem. 277:25884–25892. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schroeter H, Spencer J, Rice-Evans C and
Williams R: Flavonoids protect neurons from oxidized
low-density-lipoprotein-induced apoptosis involving c-Jun
N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J.
358:547–557. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu K, Zhao Y, Li GC and Yu WP: c-Jun
N-terminal kinase is required for vitamin E succinate-induced
apoptosis in human gastric cancer cells. World J Gastroenterol.
10:1110–1114. 2004.PubMed/NCBI
|
